116 filings
Page 4 of 6
8-K
l9xs5a5rm4tqq1c
22 Mar 19
Entry into a Material Definitive Agreement
6:30am
UPLOAD
37oxsc
22 Mar 19
Letter from SEC
12:00am
8-K
74fcn2lkyptpj
20 Mar 19
Regulation FD Disclosure
2:40pm
8-K
62n xiz09
18 Mar 19
Xynomic Pharma Achieves Important Regulatory Milestones in China and EU in Potentially Pivotal Kidney Cancer and Lymphoma Trials
7:00am
8-K
m069s4
4 Mar 19
Other Events
7:02am
PRER14A
ej8jol mvchespuvpyv
4 Mar 19
Preliminary revised proxy
7:01am
CORRESP
z2v2x3oiwg85 xn
4 Mar 19
Correspondence with SEC
12:00am
UPLOAD
1umlem383hyh67jd
1 Mar 19
Letter from SEC
12:00am
8-K
6yyyy 29e7dt05nkll7c
27 Feb 19
Entry into a Material Definitive Agreement
8:00am
PRE 14A
mcx4ncogyjko
22 Feb 19
Preliminary proxy
5:23pm
UPLOAD
24gnh8t8ft8s8l26p9
13 Feb 19
Letter from SEC
12:00am
8-K
x6qu3ac
12 Feb 19
Entry into a Material Definitive Agreement
11:08am
CORRESP
st8aix ske9cf0
12 Feb 19
Correspondence with SEC
12:00am
S-4/A
yo4kc
12 Feb 19
Registration of securities issued in business combination transactions (amended)
12:00am
UPLOAD
ivnzwp7 gf3hlcfava
8 Feb 19
Letter from SEC
12:00am
8-K
ih7vlwf
14 Jan 19
Bison Capital Acquisition Corp. & Xynomic Pharmaceuticals, Inc. Investor Presentation January 2019
12:00am
S-4
nk8 f16bcu
4 Jan 19
Registration of securities issued in business combination transactions
9:28am
CORRESP
gj555fre05k xioy5blf
4 Jan 19
Correspondence with SEC
12:00am